图像质量提高、辐射剂量与对比剂用量降低:颅内CTA的整体优化方法
研究纳入120例接受64排CT颅内CTA的患者,等量分入固定80 ml对比剂方案A与基于患者个体化对比剂公式的方案B,比较DLP与对比剂用量;方案B动脉血管平均衰减最高较方案A高56%(p<0.01),静脉系统平均衰减最高降低93%(p<0.001),平均对比剂用量方案B 53±10 ml vs 方案A 80±1 ml(p<0.001),平均DLP方案B 3.99±0.22 mSv vs 方案A 4.74±0.22 mSv(p=0.02)。
要点
- 个体化对比剂公式方案B的动脉血管平均衰减最高较固定80 ml方案A高56%(p<0.01)。
- 方案B静脉系统平均血管衰减较方案A最高降低93%(p<0.001)。
- 方案B平均对比剂用量53±10 ml,低于方案A的80±1 ml(p<0.001)。
核心结论
- 采用基于患者个体的对比剂公式行颅内CTA,可同时显著降低对比剂用量和DLP。
研究设计与样本
- 前瞻性对照研究,120例患者等量分入两种采集/对比剂方案,使用64排CT行颅内CTA;方案A为80 ml对比剂,方案B为新型对比剂公式;两方案对比剂与生理盐水注射流率均为4.5 ml/s;采用双尾独立t检验比较DLP与对比剂用量。
关键影像表现/征象
- 方案B动脉血管平均衰减最高较方案A高56%(p<0.01)。
- 方案B静脉系统平均血管衰减显著低于方案A,最高降低93%(p<0.001)。
- 两方案扫描时间相等:方案B 4.22±1.2秒,方案A 4.01±1.3秒。
诊断标准与关键数值
- 方案B平均对比剂用量53±10 ml,方案A为80±1 ml(p<0.001)。
- 方案B平均DLP 3.99±0.22 mSv,方案A为4.74±0.22 mSv(p=0.02)。
临床应用与阅片要点
- 采用基于患者个体的对比剂公式可在颅内CTA中降低对比剂用量和DLP,同时动脉血管平均衰减最高较固定80 ml方案高56%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To investigate the dose-length product (DLP) during intracranial computed tomography angiography (CTA) using a patient-specific contrast formula.
MATERIALS AND METHODS: Intracranial CTA was performed on 120 patients using 64-channel CT. Patients were subjected in equal numbers to one of two acquisitions/contrast medium protocols. Protocol A, consisted of 80 ml contrast medium and protocol B, involved a novel contrast medium formula. In each protocol, contrast medium and saline were injected at a flow rate of 4.5 ml/s. The DLP and contrast volume (CV) were measured between each protocol and the data obtained were compared using two-tailed independent t-test.
RESULTS: Mean arterial vessel attenuation was up to 56% (p<0.01) higher using protocol B compared with A. In the venous system, the mean vessel attenuation was significantly lower in protocol B than A with a maximum reduction of 93% (p<0.001). The mean CV was significantly lower in protocol B (53±10 ml) compared to A (80±1 ml, p<0.001). The scan time was equal in each protocol (B, 4.22±1.2 seconds; A, 4.01±1.3 seconds). A significant reduction in mean DLP was demonstrated in protocol B (3.99±0.22 mSv) compared to A (4.74±0.22 mSv; p=0.02).
CONCLUSION: A significant reduction in CV and DLP during intracranial CTA can be achieved when employing a patient-specific contrast medium formula.
引用
- Saade C, Al-Fout G, Mayat A, et al. Increased image quality and reduced radiation dose and contrast media volume: a holistic approach to intracranial CTA. Clin Radiol. 2017. PMID: 28477959. doi:10.1016/j.crad.2017.03.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。